Koka Lifesciences
PrivateLast Round
Early Funding
Oct 8, 2021
Total Funding Raised
$54.7M
Company Overview
Koka Lifesciences operates in Healthcare & Life Sciences and is based in Nantong. Its latest recorded funding round was an Early Funding round in October 2021.
Koka Lifesciences is a medical device company that develops and manufactures interventional heart valve devices for the treatment of structural heart diseases.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Koka Lifesciences Comparables
Compare Koka Lifesciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lepu Medical Technology | 41% | |
| Nanjing Saint Medical Technology Co., Ltd. | 39% | |
| Shanghai Hanyu Medical Technology | 34% |
For institutional investors. Book with your work email.
Koka Lifesciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 8, 2021 | ||||
| Series B | Nov 27, 2020 | ||||
| Series A | Sep 1, 2019 |
For institutional investors. Book with your work email.
Koka Lifesciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jifeng Ventures | Series B |
| Zheshang Venture Capital | Series B |
| China Zhongji Investment | Early Funding |
| CAS Star | Series A |
| Blue Ocean Capital Group | Early Funding |
| Sherpa Capital | Series B |
| 华创资本 | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2021
$55M raised led by Blue Ocean Capital Group.
- Nov 27, 2020
Raised Series B with investors including Sherpa Capital and Jifeng Ventures.
For institutional investors. Book with your work email.
Koka Lifesciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Koka Lifesciences's valuation, stock price, and market status.
Is Koka Lifesciences a public or private company?
Koka Lifesciences is a private company.
What is the current stock price of Koka Lifesciences?
Koka Lifesciences is a private company, so its shares have no public market price. Caplight tracks Koka Lifesciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Koka Lifesciences worth (valuation)?
Valuation information for Koka Lifesciences is not publicly available.
Can I buy Koka Lifesciences stock?
Koka Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Koka Lifesciences's last funding round?
Koka Lifesciences's most recent funding round was Early Funding on October 8, 2021.
Who are the main investors in Koka Lifesciences?
Key investors in Koka Lifesciences include Blue Ocean Capital Group.
Will Koka Lifesciences IPO soon?
No public IPO plans have been announced for Koka Lifesciences.
How can I track Koka Lifesciences secondary market activity?
Caplight tracks bids, offers, and trades in Koka Lifesciences's shares on secondary markets.